Threshold Values of High‐risk Echocardiographic Epicardial Fat Thickness

Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and a...

Full description

Saved in:
Bibliographic Details
Published inObesity (Silver Spring, Md.) Vol. 16; no. 4; pp. 887 - 892
Main Authors Iacobellis, Gianluca, Willens, Howard J., Barbaro, Giuseppe, Sharma, Arya M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.04.2008
Subjects
Online AccessGet full text
ISSN1930-7381
1930-739X
DOI10.1038/oby.2008.6

Cover

Abstract Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Methods and Procedures: Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m2 (22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Results: Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Discussion: Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
AbstractList Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Methods and Procedures: Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m 2 (22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Results: Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) ( P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Discussion: Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.OBJECTIVEEchocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors.Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.METHODS AND PROCEDURESEpicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated.Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.RESULTSAmong 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance.Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.DISCUSSIONMedian values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Methods and Procedures: Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30–65), median BMI 32 kg/m2 (22–52), median waist circumference 100.5 cm (85–140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Results: Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Discussion: Median values of 9.5 and 7.5 mm should be considered the threshold values for high‐risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target. In this study, we sought to provide threshold values of echocardiographic epicardial fat thickness associated with metabolic and anthropometric risk factors. Epicardial fat thickness was measured in 246 consecutive white subjects (120 women, 126 men, median age 46 years (30-65), median BMI 32 kg/m(2) (22-52), median waist circumference 100.5 cm (85-140)), who underwent routine transthoracic echocardiogram for standard clinical indications. Metabolic syndrome (MetS), Insulin resistance, BMI, and waist circumference categories were identified and epicardial fat was calculated. Among 246 subjects, 58% had MetS. These subjects showed median values of epicardial fat thickness of 9.5 and 7.5 mm (in men and women, respectively), significantly higher than those found in subjects without MetS (no MetS) (P < 0.001). Receiver operating characteristics (ROC) analysis showed that epicardial fat thickness of 9.5 and 7.5 mm maximize the sensitivity and specificity to predict MetS, in men and women, respectively. In separate analyses, median epicardial fat thickness values of 9.5 and 7.5 mm were cutoff points associated with high abdominal fat in men and women, respectively. When insulin sensitivity was considered separately, epicardial fat thickness of 9.5 mm was associated with insulin resistance. Median values of 9.5 and 7.5 mm should be considered the threshold values for high-risk echocardiographic epicardial fat thickness in white men and women, respectively. Echocardiographic epicardial fat measurement may be of help for cardiometabolic risk stratification and therapeutic interventions targeting the fat.
Author Barbaro, Giuseppe
Sharma, Arya M.
Willens, Howard J.
Iacobellis, Gianluca
Author_xml – sequence: 1
  givenname: Gianluca
  surname: Iacobellis
  fullname: Iacobellis, Gianluca
– sequence: 2
  givenname: Howard J.
  surname: Willens
  fullname: Willens, Howard J.
– sequence: 3
  givenname: Giuseppe
  surname: Barbaro
  fullname: Barbaro, Giuseppe
– sequence: 4
  givenname: Arya M.
  surname: Sharma
  fullname: Sharma, Arya M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18379565$$D View this record in MEDLINE/PubMed
BookMark eNp90cFKAzEQBuAgFW2rFx9AFgQPwtZkk91kj1qqVYReiugpZLNTN3a7qckW6c1H8Bl9EqNVDyKeEoZvfoaZHuo0tgGEDggeEEzFqS3WgwRjMci2UJfkFMec5nedn78gu6jn_SPGLMMp2UG7RFCep1naRdfTyoGvbF1Gt6pegY_sLBqbh-rt5dUZP49GurJaudLYB6eWldHRaGk-C6qOLlQbTUNt3oD3e2h7pmoP-19vH00vRtPhOL6ZXF4Nz25izVLGY50IJZQSmOi8KNOU5EpjQhgDTspUFCXnQEgpgGrGZwUUuKAp5CyDolQgaB8db2KXzj6FgVu5MF5DXasG7MpLjhlLCCcBHv2Cj3blmjCaDGvDLKFJwoM6_FKrYgGlXDqzUG4tv1cUAN4A7az3DmZSm1a1xjatU6YOWR9xQoYryI8ryCy0nPxq-Un9Cw82-NnUsP5Hysn5fU45fQfNf5do
CitedBy_id crossref_primary_10_3390_jcdd9080253
crossref_primary_10_1111_pace_13119
crossref_primary_10_1007_s10554_015_0778_8
crossref_primary_10_3390_ijms20235989
crossref_primary_10_1371_journal_pone_0019908
crossref_primary_10_1038_s41390_024_03319_9
crossref_primary_10_2217_17584299_4_1_55
crossref_primary_10_1016_j_diabres_2010_09_037
crossref_primary_10_1097_CRD_0000000000000670
crossref_primary_10_4250_jcu_2009_17_4_121
crossref_primary_10_1016_j_endonu_2013_03_004
crossref_primary_10_1016_j_jcmg_2010_05_003
crossref_primary_10_1016_j_jicc_2017_01_003
crossref_primary_10_1038_oby_2011_283
crossref_primary_10_15436_2376_0494_15_034
crossref_primary_10_3945_ajcn_2008_27358
crossref_primary_10_1515_jim_2017_0090
crossref_primary_10_1007_s00059_017_4555_4
crossref_primary_10_1161_CIRCULATIONAHA_107_721027
crossref_primary_10_3390_biom9030097
crossref_primary_10_1007_s10554_022_02579_y
crossref_primary_10_3390_jcm11164718
crossref_primary_10_1016_j_jcmg_2010_05_001
crossref_primary_10_1210_jc_2009_0436
crossref_primary_10_1177_0003319714548211
crossref_primary_10_1007_s10741_017_9644_1
crossref_primary_10_1111_j_1399_5448_2010_00644_x
crossref_primary_10_3109_10641963_2013_863324
crossref_primary_10_1016_j_clnu_2008_10_006
crossref_primary_10_1016_j_jacl_2016_02_006
crossref_primary_10_1159_000484326
crossref_primary_10_1016_j_exger_2012_09_005
crossref_primary_10_7326_aimcc_2022_0056
crossref_primary_10_1515_jce_2017_0003
crossref_primary_10_31832_smj_486781
crossref_primary_10_2169_internalmedicine_54_3714
crossref_primary_10_1016_j_hipert_2010_12_003
crossref_primary_10_1038_oby_2011_155
crossref_primary_10_2147_JIR_S326769
crossref_primary_10_1016_j_atherosclerosis_2012_07_014
crossref_primary_10_1016_j_arcmed_2017_06_010
crossref_primary_10_1053_j_jvca_2019_08_053
crossref_primary_10_1177_0003319712450310
crossref_primary_10_1016_j_biomag_2011_06_001
crossref_primary_10_1177_10742484211006997
crossref_primary_10_1016_j_cjca_2025_01_029
crossref_primary_10_1177_1479164119827602
crossref_primary_10_1016_j_ebiom_2022_103864
crossref_primary_10_3390_nu14142926
crossref_primary_10_1021_pr500434s
crossref_primary_10_31146_1682_8658_ecg_222_2_101_110
crossref_primary_10_1016_j_atherosclerosis_2014_12_058
crossref_primary_10_3390_ijerph18063136
crossref_primary_10_1016_j_recesp_2013_10_013
crossref_primary_10_1152_ajpheart_00175_2014
crossref_primary_10_1016_j_numecd_2021_10_011
crossref_primary_10_1016_j_nut_2018_07_002
crossref_primary_10_1111_pedi_12893
crossref_primary_10_1038_oby_2008_575
crossref_primary_10_1016_S2171_3669_11_70023_3
crossref_primary_10_1093_eurheartj_ehr453
crossref_primary_10_3390_jcm7050113
crossref_primary_10_1016_j_numecd_2022_08_005
crossref_primary_10_1016_j_ejogrb_2021_12_020
crossref_primary_10_1186_s12933_017_0528_4
crossref_primary_10_1038_oby_2009_363
crossref_primary_10_1186_1757_2215_7_24
crossref_primary_10_1080_07315724_2014_933685
crossref_primary_10_1155_2015_456293
crossref_primary_10_1016_j_recesp_2016_07_025
crossref_primary_10_16899_jcm_577187
crossref_primary_10_1016_j_numecd_2022_03_003
crossref_primary_10_1016_j_rec_2013_10_011
crossref_primary_10_36660_ijcs_20190179
crossref_primary_10_4239_wjd_v11_i2_33
crossref_primary_10_1016_j_amjcard_2012_08_044
crossref_primary_10_1016_j_echo_2009_10_013
crossref_primary_10_1371_journal_pone_0074926
crossref_primary_10_1016_j_echo_2010_11_008
crossref_primary_10_20538_1682_0363_2018_4_254_263
crossref_primary_10_1111_j_1476_5381_2011_01479_x
crossref_primary_10_1016_j_numecd_2016_11_001
crossref_primary_10_1016_j_jelectrocard_2020_05_009
crossref_primary_10_1016_j_echo_2011_09_018
crossref_primary_10_1007_s00246_013_0799_9
crossref_primary_10_25259_IJDVL_214_19
crossref_primary_10_5812_cardiovascmed_4_2_2015_25679
crossref_primary_10_1186_1471_2261_14_3
crossref_primary_10_1016_j_amjcard_2011_07_031
crossref_primary_10_1186_s12944_016_0371_8
crossref_primary_10_20862_0042_4676_2019_100_6_387_394
crossref_primary_10_4178_epih_e2023001
crossref_primary_10_1007_s11845_020_02339_8
crossref_primary_10_1016_j_numecd_2015_10_013
crossref_primary_10_1007_s40618_014_0199_x
crossref_primary_10_1016_j_tria_2022_100175
crossref_primary_10_1016_j_endoen_2012_08_013
crossref_primary_10_14341_omet9295
crossref_primary_10_1177_2047487317724342
crossref_primary_10_1007_s12020_024_04077_8
crossref_primary_10_1016_j_endoen_2011_06_002
crossref_primary_10_4236_ijcm_2011_24062
crossref_primary_10_1016_j_amjcard_2010_01_368
crossref_primary_10_1111_echo_13600
crossref_primary_10_1155_2013_769175
crossref_primary_10_1007_BF03346676
crossref_primary_10_36660_ijcs_20200363
crossref_primary_10_1016_j_numecd_2011_09_001
crossref_primary_10_1161_CIRCRESAHA_115_307765
crossref_primary_10_1038_nrendo_2015_58
crossref_primary_10_1016_j_atherosclerosis_2012_05_033
crossref_primary_10_1016_j_atherosclerosis_2021_02_008
crossref_primary_10_1002_ejhf_2709
crossref_primary_10_1016_j_ehj_2018_04_002
crossref_primary_10_1016_j_numecd_2020_11_005
crossref_primary_10_1016_j_rec_2016_08_001
crossref_primary_10_14341_omet2018229_34
crossref_primary_10_1016_j_numecd_2015_04_011
crossref_primary_10_1016_j_cjca_2014_12_008
crossref_primary_10_1049_iet_spr_2011_0170
crossref_primary_10_1186_s12933_017_0650_3
crossref_primary_10_1093_cvr_cvz062
crossref_primary_10_14341_omet12614
crossref_primary_10_1016_j_endoen_2013_12_007
crossref_primary_10_1007_s00059_014_4146_6
crossref_primary_10_1016_j_numecd_2008_06_007
crossref_primary_10_1111_ijpo_227
crossref_primary_10_1016_j_jchf_2020_04_016
crossref_primary_10_1111_j_1582_4934_2010_01141_x
crossref_primary_10_1002_mco2_413
crossref_primary_10_1016_j_ijcard_2012_06_011
crossref_primary_10_1016_j_echo_2015_07_006
crossref_primary_10_1097_MEG_0000000000002375
crossref_primary_10_1007_s40618_014_0066_9
crossref_primary_10_1089_met_2013_0107
crossref_primary_10_1016_j_cgh_2018_11_011
crossref_primary_10_1016_j_numecd_2023_10_016
crossref_primary_10_1016_j_endonu_2011_06_002
crossref_primary_10_1111_j_2047_6310_2012_00134_x
crossref_primary_10_1002_oby_20090
crossref_primary_10_1016_j_numecd_2017_05_009
crossref_primary_10_1002_cbf_1706
crossref_primary_10_1016_j_numecd_2020_03_016
crossref_primary_10_1016_j_tem_2011_07_003
crossref_primary_10_1080_10641955_2017_1321016
crossref_primary_10_1016_j_arteri_2011_08_003
crossref_primary_10_1016_S1575_0922_08_75079_4
crossref_primary_10_18621_eurj_1180149
crossref_primary_10_1007_s12020_013_0099_4
crossref_primary_10_1016_j_amjcard_2009_07_032
crossref_primary_10_7759_cureus_51698
crossref_primary_10_1186_s12872_020_01480_7
crossref_primary_10_13048_jkm_17043
crossref_primary_10_1007_s00508_015_0722_x
crossref_primary_10_3390_biology11030355
crossref_primary_10_1007_s40477_019_00368_3
crossref_primary_10_1038_ajh_2011_134
crossref_primary_10_1016_j_amjcard_2012_07_045
crossref_primary_10_1016_j_atherosclerosis_2017_06_017
crossref_primary_10_1177_2047487317717820
crossref_primary_10_3390_jcm10225455
crossref_primary_10_1016_j_ijcard_2018_06_106
crossref_primary_10_1007_s12020_014_0460_2
crossref_primary_10_3109_08037051_2011_649538
crossref_primary_10_3390_ijms24076838
crossref_primary_10_1016_j_endonu_2012_08_001
crossref_primary_10_1007_s15034_020_2137_7
crossref_primary_10_1016_j_bionut_2011_06_024
crossref_primary_10_3109_14017431_2013_824604
crossref_primary_10_1016_j_amjcard_2012_06_003
crossref_primary_10_18705_1607_419X_2022_28_3_260_269
crossref_primary_10_1177_11795468211041330
crossref_primary_10_1186_1743_8977_10_43
crossref_primary_10_3390_ijms21020520
crossref_primary_10_1159_000488064
crossref_primary_10_1007_s11739_022_02966_2
crossref_primary_10_1038_ijo_2011_117
crossref_primary_10_3389_fcvm_2021_658445
crossref_primary_10_1186_1476_7120_12_35
crossref_primary_10_1007_s12350_015_0370_6
Cites_doi 10.1038/oby.2006.192
10.1007/BF00280883
10.1210/jc.2006-0594
10.2337/diabetes.47.10.1643
10.1016/S0079-6123(03)46018-4
10.1038/oby.2007.591
10.1016/j.ijcard.2006.08.061
10.1016/j.atherosclerosis.2005.08.004
10.1016/j.amjcard.2006.12.042
10.1186/1475-2840-5-1
10.1210/jc.2006-0584
10.1016/j.amjcard.2004.06.075
10.1210/jc.2003-030698
10.1016/j.ejrad.2005.12.030
10.1253/circj.71.536
10.1016/j.carpath.2004.08.005
10.1210/jc.2005-0091
10.1210/jc.2005-1087
10.1161/01.CIR.0000099542.57313.C5
10.1038/ncpcardio0319
10.1161/01.CIR.0000111245.75752.C6
10.1016/j.amjcard.2006.12.082
10.1210/jc.2006-1044
10.1038/oby.2003.45
10.1016/j.amjcard.2006.08.045
10.1016/j.ijcard.2006.04.016
10.1016/j.ahj.2007.03.019
ContentType Journal Article
Copyright 2008 North American Association for the Study of Obesity (NAASO)
Copyright Nature Publishing Group Apr 2008
Copyright_xml – notice: 2008 North American Association for the Study of Obesity (NAASO)
– notice: Copyright Nature Publishing Group Apr 2008
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1038/oby.2008.6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1930-739X
EndPage 892
ExternalDocumentID 2725869181
18379565
10_1038_oby_2008_6
OBY937
Genre article
Clinical Trial
Validation Studies
Journal Article
GroupedDBID ---
05W
0R~
123
1OC
29N
2FS
2WC
31~
33P
39C
3SF
4.4
50Y
52U
52V
53G
70F
8-1
AAESR
AAEVG
AAFWJ
AAHBH
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABIVO
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZVAB
BAWUL
BFHJK
BHBCM
BKNYI
BMXJE
BOGZA
BPHCQ
BRXPI
BVXVI
CS3
DCZOG
DIK
DPXWK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
F5P
FUBAC
G-S
GODZA
HGLYW
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
O66
O9-
OK1
P2W
PQQKQ
PROAC
R.K
ROL
SUPJJ
WBKPD
WHG
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WQJ
WVDHM
WXSBR
YHZ
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c4547-c28a8aa801c9bd5519ac01144e71d58bd77e11d8e3c47fbeb0b35e946ebdae83
ISSN 1930-7381
IngestDate Sun Aug 24 02:53:15 EDT 2025
Fri Jul 25 23:54:49 EDT 2025
Thu Apr 03 06:58:06 EDT 2025
Tue Jul 01 01:15:56 EDT 2025
Thu Apr 24 23:00:10 EDT 2025
Wed Aug 20 07:27:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4547-c28a8aa801c9bd5519ac01144e71d58bd77e11d8e3c47fbeb0b35e946ebdae83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/oby.2008.6
PMID 18379565
PQID 1030423227
PQPubID 105348
PageCount 6
ParticipantIDs proquest_miscellaneous_70442171
proquest_journals_1030423227
pubmed_primary_18379565
crossref_citationtrail_10_1038_oby_2008_6
crossref_primary_10_1038_oby_2008_6
wiley_primary_10_1038_oby_2008_6_OBY937
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2008
PublicationDateYYYYMMDD 2008-04-01
PublicationDate_xml – month: 04
  year: 2008
  text: April 2008
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: United States
– name: Silver Spring
PublicationTitle Obesity (Silver Spring, Md.)
PublicationTitleAlternate Obesity (Silver Spring)
PublicationYear 2008
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2007; 115
1985; 28
2006; 91
2003; 108
2004; 94
2004; 146
1989; 43
2006; 13
2005; 90
2007; 121
2006; 14
2007; 153
2004; 13
2006; 186
2007; 71
2005; 2
2004; 109
2007; 99
2005; 29
2003; 88
2003; 11
1998; 47
2007; 15
2005; 57
Iacobellis G. (e_1_2_6_5_2) 2005; 29
e_1_2_6_30_2
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_12_2
e_1_2_6_13_2
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_20_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
Schejbal V. (e_1_2_6_10_2) 1989; 43
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – volume: 115
  start-page: 272
  year: 2007
  end-page: 273
  article-title: Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects
  publication-title: Int J Cardiol
– volume: 57
  start-page: 417
  year: 2005
  end-page: 422
  article-title: Mapping epicardial fat with multidetector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation
  publication-title: Eur J Radiol
– volume: 91
  start-page: 2906
  year: 2006
  end-page: 2912
  article-title: Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease
  publication-title: J Clin Endocrinol Metab
– volume: 121
  start-page: 132
  year: 2007
  end-page: 134
  article-title: Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity
  publication-title: Int J Cardiol
– volume: 91
  start-page: 4620
  year: 2006
  end-page: 4627
  article-title: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance
  publication-title: J Clin Endocrinol Metab
– volume: 13
  start-page: 313
  year: 2004
  end-page: 316
  article-title: The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts
  publication-title: Cardiovasc Pathol
– volume: 88
  start-page: 5163
  year: 2003
  end-page: 5168
  article-title: Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk
  publication-title: J Clin Endocrinol Metab
– volume: 11
  start-page: 304
  year: 2003
  end-page: 310
  article-title: Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction
  publication-title: Obes Res
– volume: 109
  start-page: 433
  year: 2004
  end-page: 438
  article-title: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
  publication-title: Circulation
– volume: 94
  start-page: 1084
  year: 2004
  end-page: 1087
  article-title: Relation between epicardial adipose tissue and left ventricular mass
  publication-title: Am J Cardiol
– volume: 153
  start-page: 907
  year: 2007
  end-page: 917
  article-title: Human epicardial adipose tissue: a review
  publication-title: Am Heart J
– volume: 108
  start-page: 2460
  year: 2003
  end-page: 2466
  article-title: Human epicardial adipose tissue is a source of inflammatory mediators
  publication-title: Circulation
– volume: 146
  start-page: 279
  year: 2004
  end-page: 289
  article-title: Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?
  publication-title: Prog Brain Res
– volume: 47
  start-page: 1643
  year: 1998
  end-page: 1649
  article-title: Prevalence of insulin resistance in metabolic disorders
  publication-title: Diabetes
– volume: 99
  start-page: 1242
  year: 2007
  end-page: 1245
  article-title: Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography
  publication-title: Am J Cardiol
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  article-title: Homeostasis model assessment: insulin resistance and ‐cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 15
  start-page: 870
  year: 2007
  end-page: 878
  article-title: Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging
  publication-title: Obesity
– volume: 99
  start-page: 1470
  year: 2007
  end-page: 1472
  article-title: Relation of subepicardial adipose tissue to carotid intima‐media thickness in patients with human immunodeficiency virus
  publication-title: Am J Cardiol
– volume: 186
  start-page: 354
  year: 2006
  end-page: 359
  article-title: Subepicardial adipose tissue and the presence and severity of coronary artery disease
  publication-title: Atherosclerosis
– volume: 90
  start-page: 6300
  year: 2005
  end-page: 6302
  article-title: Epicardial adipose tissue and insulin resistance in obese subjects
  publication-title: J Clin Endocrinol Metab
– volume: 14
  start-page: 1679
  year: 2006
  end-page: 1684
  article-title: Different “weight” of cardiac and general adiposity in predicting left ventricle morphology
  publication-title: Obesity
– volume: 29
  start-page: 251
  year: 2005
  end-page: 255
  article-title: Adiponectin expression in human epicardial adipose tissue is lower in patients with coronary artery disease
  publication-title: Cytokine
– volume: 90
  start-page: 3978
  year: 2005
  end-page: 3982
  article-title: Endothelial function, carotid artery intima‐media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone‐deficient adolescents: apparent effects of growth hormone treatment on these parameters
  publication-title: J Clin Endocrinol Metab
– volume: 43
  start-page: 490
  year: 1989
  end-page: 499
  article-title: Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance
  publication-title: Pneumologie
– volume: 91
  start-page: 4689
  year: 2006
  end-page: 4695
  article-title: Myocardial triglyceride content and epicardial adipose mass in human obesity: relationship to left ventricular function and serum free fatty acid levels
  publication-title: J Clin Endocrinol Metab
– volume: 2
  start-page: 536
  year: 2005
  end-page: 543
  article-title: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart
  publication-title: Nat Clin Pract Cardiovasc Med
– volume: 71
  start-page: 536
  year: 2007
  end-page: 539
  article-title: Echocardiographic epicardial fat thickness and coronary artery disease
  publication-title: Circ J
– volume: 13
  start-page: 1
  year: 2006
  article-title: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
  publication-title: Cardiovasc Diabetol
– volume: 99
  start-page: 541
  year: 2007
  end-page: 548
  article-title: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations
  publication-title: Am J Cardiol
– ident: e_1_2_6_3_2
  doi: 10.1038/oby.2006.192
– ident: e_1_2_6_25_2
  doi: 10.1007/BF00280883
– ident: e_1_2_6_23_2
  doi: 10.1210/jc.2006-0594
– ident: e_1_2_6_26_2
  doi: 10.2337/diabetes.47.10.1643
– ident: e_1_2_6_8_2
  doi: 10.1016/S0079-6123(03)46018-4
– ident: e_1_2_6_28_2
  doi: 10.1038/oby.2007.591
– ident: e_1_2_6_27_2
  doi: 10.1016/j.ijcard.2006.08.061
– ident: e_1_2_6_19_2
  doi: 10.1016/j.atherosclerosis.2005.08.004
– ident: e_1_2_6_22_2
  doi: 10.1016/j.amjcard.2006.12.042
– ident: e_1_2_6_7_2
  doi: 10.1186/1475-2840-5-1
– ident: e_1_2_6_17_2
  doi: 10.1210/jc.2006-0584
– volume: 43
  start-page: 490
  year: 1989
  ident: e_1_2_6_10_2
  article-title: Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance
  publication-title: Pneumologie
– ident: e_1_2_6_12_2
  doi: 10.1016/j.amjcard.2004.06.075
– ident: e_1_2_6_15_2
  doi: 10.1210/jc.2003-030698
– ident: e_1_2_6_29_2
  doi: 10.1016/j.ejrad.2005.12.030
– ident: e_1_2_6_18_2
  doi: 10.1253/circj.71.536
– ident: e_1_2_6_11_2
  doi: 10.1016/j.carpath.2004.08.005
– ident: e_1_2_6_21_2
  doi: 10.1210/jc.2005-0091
– ident: e_1_2_6_14_2
  doi: 10.1210/jc.2005-1087
– ident: e_1_2_6_6_2
  doi: 10.1161/01.CIR.0000099542.57313.C5
– ident: e_1_2_6_2_2
  doi: 10.1038/ncpcardio0319
– ident: e_1_2_6_24_2
  doi: 10.1161/01.CIR.0000111245.75752.C6
– ident: e_1_2_6_16_2
  doi: 10.1016/j.amjcard.2006.12.082
– volume: 29
  start-page: 251
  year: 2005
  ident: e_1_2_6_5_2
  article-title: Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease
  publication-title: Cytokine
– ident: e_1_2_6_9_2
  doi: 10.1210/jc.2006-1044
– ident: e_1_2_6_20_2
  doi: 10.1038/oby.2003.45
– ident: e_1_2_6_30_2
  doi: 10.1016/j.amjcard.2006.08.045
– ident: e_1_2_6_13_2
  doi: 10.1016/j.ijcard.2006.04.016
– ident: e_1_2_6_4_2
  doi: 10.1016/j.ahj.2007.03.019
SSID ssj0046051
Score 2.3607845
Snippet Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and...
Objective: Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and...
Echocardiographic epicardial adipose tissue is a new index of cardiac and visceral adiposity with great potential as a diagnostic tool and therapeutic target....
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 887
SubjectTerms Adult
Aged
Echocardiography - methods
Echocardiography - standards
Echocardiography - statistics & numerical data
Female
Humans
Insulin Resistance
Intra-Abdominal Fat - diagnostic imaging
Male
Metabolic Syndrome - diagnostic imaging
Metabolic Syndrome - epidemiology
Middle Aged
Obesity - diagnostic imaging
Obesity - epidemiology
Observer Variation
Pericardium - diagnostic imaging
Reference Values
Risk Factors
ROC Curve
Sensitivity and Specificity
Title Threshold Values of High‐risk Echocardiographic Epicardial Fat Thickness
URI https://onlinelibrary.wiley.com/doi/abs/10.1038%2Foby.2008.6
https://www.ncbi.nlm.nih.gov/pubmed/18379565
https://www.proquest.com/docview/1030423227
https://www.proquest.com/docview/70442171
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELbKIiEuiH-yu0AkkBCKUpLajZ0joC67RYXDFrScIsdxpIpVUm2bw3LiBZB4Rp6EGTt_pRVauESV69Sp5_N4ZvxlhpDnlEUiDVLppxlPfUZz5YNnq3wwNrIsj5lgEuMdsw_R8Sc2PRufDQY_eqylap0O1bed75X8j1ShDeSKb8n-g2TbH4UG-AzyhStIGK5XlDE4y3h-5H2W55VNH4vEjZbBYIjjE9BwytBOTXbqhfImy4VpAPEcyTXW7lRfi4aKUVuqdcUAtEBPF0if9mwM0ERQs2EvgnACShWPL2y2gneAN6yk1g_oaGusW4quNx124VM87CjtbdVKL5ctzE5NSm2juS4upTcbboQnRI_VYjVqTAOfU1uXZaj7baaGbqeGox7cWE-ninpHrrdnWzpvS_PbPO9lemn5sTvSa_-x7bVkRHMMT0UC99qinNE1cn3EwRRDG_vkfbOx4wlyaEkK9h812W6peNWNu2nfbDktmz6QMWLmt8mt2vtwX1so3SEDXdwlN2Y1v-IembaIci2i3DJ3EVG_vv9ELLlbWHI7LLmAJbfF0n0yP5rM3x77dbUNX2FSN1-NhBRSgsWi4jQDQzqWCr1lpnmYjQWsZa7DMBOaKsbzVMMKp2Mds0inmdSCPiB7RVnoR8TlgQypDDXlucTwgQhinUkZBjofM5glh7xspihRdSZ6LIhynmyLwiHP2r5Lm39lZ6_DZqaTen2usA-SvkYj7pCn7degPfFITBa6rFYJDxgDpzx0yEMrn24QQXkM3o5DXhiB_WX05OObL2Dl71_pUQ_IzW6ZHJK99UWlH4Ndu06fGLT9BhP1oXE
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Threshold+Values+of+High%E2%80%90risk+Echocardiographic+Epicardial+Fat+Thickness&rft.jtitle=Obesity+%28Silver+Spring%2C+Md.%29&rft.au=Iacobellis%2C+Gianluca&rft.au=Willens%2C+Howard+J.&rft.au=Barbaro%2C+Giuseppe&rft.au=Sharma%2C+Arya+M.&rft.date=2008-04-01&rft.issn=1930-7381&rft.eissn=1930-739X&rft.volume=16&rft.issue=4&rft.spage=887&rft.epage=892&rft_id=info:doi/10.1038%2Foby.2008.6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_oby_2008_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1930-7381&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1930-7381&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1930-7381&client=summon